IKT   $2.13  -9.36% Market Closed After Close 2.2 3.29%

Inhibikase Therapeutics Inc
Total Cash 7.94M
totalCashPerShare 1.064
EBITDA -18.98M
Total Debt 355.09K
quickRatio 2.143
currentRatio 2.322
Total Revenue 79.57K
debtToEquity 6.967
Revenue/Share 0.014
ROA -0.76206
ROE -1.4968699
grossProfits
freeCashflow -10.34M
operatingCashflow -16.47M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -238.85052
profitMargins 0.0
enterpriseValue 5.18M
forwardPE -11.121764
floatShares 5.35M
sharesOutstanding 7.46M
sharesShort 44.11K
sharesShortPriorMonth 44.04K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.12%
heldPercentInstitutions 0.23%
Short Ratio help_outline 2.37%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 0.706
Price To Book help_outline 2.68
earningsQuarterlyGrowth
netIncomeToCommon -18.38M
trailingEps -3.21%
forwardEps -0.17%
enterpriseToEbitda -0.27
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.06 3Q 2024
institutionsCount 14
lastUpdated Oct. 16, 2024, 9:58 p.m.